Carfentanil-xylazine (CX) has been the primary drug combination used for immobilizing free-ranging ungulates in Alaska, US since 1986. We investigated the efficacy of a potential new drug of choice, thiafentanil (Investigational New Animal Drug A-3080). Captive trials indicated that thiafentanil-azaperone-medetomidine could provide good levels of immobilization. However, field trials conducted in October 2013 on free-ranging caribou ( Rangifer tarandus granti) calves showed the combination too potent, causing three respiratory arrests and one mortality. The protocol was revised to thiafentanil-azaperone-xylazine (TAX), with good results. The induction time was not significantly different between the two combinations. However, the recovery time was significantly shorter for the TAX group than for the CX group. A physiologic evaluation was performed on 12 animals immobilized on CX and 15 animals on TAX. Arterial blood was collected after induction and again after 10 min of intranasal oxygen supplements (1 L/min). Both groups had significant increases in partial pressure of arterial oxygen after oxygen treatment. There was a concurrent significant increase in partial pressure of arterial carbon dioxide in both groups. Rectal temperature increased significantly in both groups during the downtime, which is consistent with other studies of potent opioids in ungulates. On the basis of our results, we found TAX to be a potential alternative for the current CX protocol for immobilizing free-ranging caribou calves via helicopter darting.

BackgroundThe effect of intranasal oxygen and/or early reversal of xylazine with atipamezole on arterial oxygenation in free-ranging moose (Alces alces) immobilized with etorphine-acepromazine-xylazine with a cross-sectional clinical study on 33 adult moose was evaluated.Moose were darted from a helicopter with 3.37 mg etorphine, 15 mg acepromazine and 75 mg xylazine. Intranasal oxygen at a flow rate of 4 L/min and/or early reversal of xylazine with 7.5 mg atipamezole to improve oxygenation was evaluated, using four treatment regimens; intranasal oxygen (n = 10), atipamezole intramuscularly (n = 6), atipamezole intravenously (n = 10), or a combination of atipamezole intravenously and intranasal oxygen (n = 7). Arterial blood was collected 7–30 minutes (min) after darting, and again 15 min after institution of treatment and immediately analyzed using an i-STAT®1 Portable Clinical Analyzer.ResultsBefore treatment the mean ± SD (range) partial pressure of arterial oxygen (PaO2) was 62 ± 17 (26–99) mmHg. Twenty-six animals had a PaO2 < 80 mmHg. Ten had a PaO2 of 40–60 mmHg and three animals had a PaO2 < 40 mmHg. Intranasal oxygen and intravenous administration of atipamezole significantly increased the mean PaO2, as did the combination of the two. In contrast, atipamezole administered intramuscularly at the evaluated dose had no significant effect on arterial oxygenation.ConclusionsThis study shows that intranasal oxygen effectively improved arterial oxygenation in immobilized moose, and that early intravenous reversal of the sedative component, in this case xylazine, in an opioid-based immobilization drug-protocol significantly improves arterial oxygenation.

No abstract

Twenty-three muskoxen ( Ovibos moschatus ) housed in a captive facility for rewilding in Sweden were chemically immobilized for annual health evaluations and hoof trimming. The muskoxen were darted in May to September (2012-15) in their holding pen with etorphine (0.015 mg/kg) and xylazine (0.1 mg/kg) intramuscularly. Twenty-two of the 23 animals were immobilized with a single dart injection. The mean (SD) induction time was 4 (2) min. Arterial blood gases were collected from 18 animals. All animals were severely hypoxemic with varying degrees of respiratory acidosis. The hypoxemia resolved in 17 of 18 animals with intranasal oxygen supplementation at 1 L/min per 100 kg. Relative arterial oxygen saturation (SpO) measured by pulse oximetry was significantly higher than the arterial oxygen saturation calculated from the partial pressure of arterial oxygen (SaO) obtained by a blood gas analyzer. Based on these findings, muskox can be immobilized successfully with etorphine (0.015 mg/kg) and xylazine (0.1 mg/kg) but should receive supplemental oxygen.

No abstract